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ABSTRACT  
Objectives 
To assess the prevalence of mild to moderate distress in patients with end stage renal disease and 
determine the association between distress and patient characteristics.  
 
Design 
Cross-sectional survey using the emotion thermometers and distress thermometer problem list. 
 
Setting 
Renal units in four hospital Trusts in the West Midlands, UK. 
 
Participants 
Adult patients with stage 5 chronic kidney disease who were: i) pre-renal replacement therapy; ii) on dialysis 
for less than 2 years; iii) on dialysis for 2 or more years, or iv) with a functioning transplant. 
 
Outcomes 
The prevalence of mild to moderate distress, and the incidence of distress thermometer problems and 
patient support needs. 
 
Results 
In total, 1040/3730 surveys were returned (27.9%). One third of survey respondents met the criteria for mild 
to moderate distress (n=346; 33.3%). Prevalence was highest in patients on dialysis for two or more years 
(n=109/300; 36.3%) and lowest in transplant patients (n=118/404; 29.2%). Prevalence was significantly 
higher in younger vs. older patients (X2=14.33; p=0.0008), in females vs. males (X2=6.63; p=0.01) and in 
black and minority ethnic patients vs. patients of white ethnicity (X2=10.36; p=0.013). Over forty per cent of 
patients (n=141) reported needing support.  More than 95% of patients reported physical problems and 
91.9% reported at least one emotional problem. 
 
Conclusions 
Mild to moderate distress is common in patients with end stage renal disease, and there may be substantial 
unmet support needs. Regular screening could help identify patients whose distress may otherwise remain 
undetected. Further research into differences in distress prevalence over time and at specific transitional 
points across the renal disease pathway is needed, as is work to determine how best to support patients 
requiring help.  
 
KEY WORDS 
Chronic Kidney Disease, Distress, End Stage Renal Disease, emotion thermometers, survey  
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STRENGTHS AND LIMITATIONS OF THIS STUDY 
 
 This study is the first to explore the prevalence of mild to moderate distress in a large cohort of patients 
with end stage renal disease (ESRD) 
 
 Findings suggest that distress affects around a third of patients with ESRD at any one time, and that there 
are substantial unmet support needs in this population 
 
 The inclusion of multiple study sites is likely to have minimised any bias arising from variations in the 
organisation and delivery of renal services 
 
 The survey response rate was low, and younger patients, those from black and minority ethnic (BME) 
groups and patients who had been more recently diagnosed were under-represented in responses. 
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BACKGROUND 
In 2016, there were 51,672 patients with end stage renal disease (ESRD) receiving renal replacement 
therapy (RRT) in England.1 Treatment is life-sustaining but not curative, and patients must constantly adjust 
to frequent changes to health status and likelihood of survival. Consequently, patients can experience many 
emotional and psychological stressors, including acceptance of diagnosis, disease progression, choosing 
treatment options, coping with dialysis, and associated impacts on employment, relationships and lifestyle.2,3 
Evidence suggests that patients with ESRD experience rates of depression and anxiety markedly higher 
than the general population.4,5 Establishing prevalence is challenging, partly because many uraemic 
symptoms can be misinterpreted as symptoms of depression,6 and partly due to the variation in prevalence 
estimates obtained using different diagnostic tools and modes of assessment (e.g. self-reported vs. 
interview-based scales).7 Consequently, depression and anxiety prevalence estimates reported in the ESRD 
literature range from around 6% to 71%,8 but are generally considered to be between 20 to 30% for dialysis 
patients9 and around 25% for transplant patients.10 This compares to a point prevalence of depression of 
between 2 and 9% and lifetime depression risk of around 7% in the general population.11  
 
Untreated anxiety and depression in patients with ESRD are associated with decreased health-related 
quality of life and higher symptom burden.12 These factors may raise the risk of poor outcomes, increased 
healthcare use, and sub-optimal adherence with diet and medication regimes.13-15 There is also evidence 
that depression status is associated with an elevated risk of all-cause mortality in renal patients, with meta-
analysis suggesting an excess mortality risk attributable to depression higher than that observed in other 
chronic diseases such as cancer and diabetes.7 Provision of emotional and psychological support is central 
to the recommended management of renal disease, and both the United Kingdom Department of Health and 
NICE (National Institute for Health and Care Excellence) mandate provision of such support within national 
renal guidelines.16,17 
 
Whilst supportive services are relatively advanced for those with higher level needs requiring psychiatric or 
psychological intervention, there is a lack of robust data on the prevalence of lower-level support needs – 
defined as difficulties adjusting to, and coping effectively with, renal failure, diagnosis, physical symptoms 
and treatment. It may also be useful to broaden the focus beyond narrowly-defined anxiety and depression 
to consider the determinants and consequences of more general emotional and psychological difficulty 
encompassed by the term ‘distress’. Whilst linear progression from lower-level to severe difficulty is not 
inevitable, timely identification of patient distress may facilitate effective management. This study aimed to 
assess the prevalence of mild to moderate distress in a cohort of patients with ESRD and determine the 
association between distress and sociodemographic and clinical characteristics. It forms part of a larger 
mixed methods study that aims to understand how the recognition and management of patients’ emotional 
and psychological support needs can be integrated into the ESRD pathway.18 
 
METHODS 
The study used a cross-sectional survey, distributed by post to all eligible patients with ESRD managed at 
four National Health Service (NHS) hospital Trusts in the West Midlands, UK. Trusts were chosen to 
maximise diversity in patient demographics, catchment size, urban-rural mix and the organisation of 
psychological support services: site 1 (small) and site 2 (large) both serve urban, inner city catchments with 
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substantial black and minority ethnic (BME) populations. Site 3 (medium) and site 4 (large) both serve 
predominantly white populations in urban areas with surrounding rural districts. Sites 2 and 4 have access to 
a renal psychologist for the provision of psychological support services, whereas sites 1 and 3 do not.  
 
Participants and recruitment 
Eligible patients were aged 18+ years, diagnosed with chronic kidney disease (CKD) stage 5, and grouped 
according to their stage on the ESRD pathway: i) pre-RRT, ii) on peritoneal or haemodialysis for less than 
two years, iii) on dialysis for two or more years, or iv) with a functioning transplant. Although differentiating 
according to dialysis vintage is not a recognised clinical distinction, it was hypothesised by the clinicians 
involved in designing this study that there may be differences in distress prevalence between patients 
initiating dialysis more recently vs. those undergoing dialysis for longer. Patients using psychiatric services 
since CKD5 diagnosis were excluded. Renal unit staff at each Trust identified eligible patients from hospital 
records, and survey packs were prepared on Trust premises by the University research team. Eligible 
patients received a letter of invitation from the renal unit’s lead consultant, an information sheet and a 
survey, to be returned directly to the researchers. Return envelopes were marked with a unique identifier for 
recording returns, and non-responders received one reminder after six weeks. Mailings were carried out 
between January 2016 and May 2017.  
 
Survey 
The survey measured distress with the Emotion Thermometers (ET),19,20 which use a visual analogue scale 
covering five domains: distress, anxiety, depression, anger and perceived need for help. Patients score each 
domain on an 11-point Likert scale to rate their levels of emotional upset during the preceding week, where 
‘0’ corresponds to none and ‘10’ denotes extreme problems. Although not validated specifically for use with 
renal patients, the ET has been widely used in studies of patients with cancer and other chronic conditions 
where it has been found to be sensitive in identifying emotional difficulty and broadly defined distress.19 It 
incorporates the distress thermometer (DT), which has been validated in the UK population with chronic 
kidney disease.21  The survey also included the Distress Thermometer Problem List22 which lists 36 
problems across five domains: practical (n=5), family (n=3), emotional (n=6), spiritual (n=1) and physical 
(n=21). Patients indicated which (if any) of the 36 problems they had experienced in the previous week. 
Closed questions covered sociodemographic characteristics (age, sex, ethnicity) and treatment modality 
(where relevant).  
 
Data analysis 
Thresholds for distress using the ET have been validated,19,20 with a score of 4 to 5 denoting mild distress, 
and 6 to 7 denoting moderate distress. Patients were defined as having mild to moderate distress if they: a) 
scored between 4 to 7 on the DT (regardless of scores in the other ET domains), or b) scored 0 to 3 on the 
DT and 4 to 7 on one or more of the anxiety, depression and anger thermometers, with no thermometer 
exceeding 7. Analysis was descriptive, focusing on associations between distress and respondents’ stage on 
the ESRD pathway and sociodemographic characteristics. Anonymised data were obtained from hospital 
information systems to allow a comparison of the characteristics of respondents and non-respondents on the 
basis of age group, sex, ethnic group and ESRD pathway stage. Comparisons were undertaken using chi-
squared analysis. Any surveys in which the emotion thermometers were left blank by a respondent were 
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excluded from analysis. The prevalence of total and individual problems from the DT problem list were 
analysed descriptively, and medians and inter-quartile ranges were calculated to compare numbers of 
problems cited within each domain. Data were analysed using SPSS (version 21.0, Armonk, NY: IBM Corp).  
 
Sample size 
The primary outcome was the difference in the prevalence of mild to moderate distress across patients at 
different ESRD stages. We anticipated an average prevalence of 25% across all patients,9 with patients in 
the stages with the highest and lowest prevalence at +/- 5 percentage points from this average (i.e. 20% for 
the stage with the lowest prevalence and 30% for the stage with the highest prevalence). This equated to a 
small effect size (w) of approximately 0.1. To detect this difference with 80% power and 5% significance, a 
total of 1090 responses were required (assuming approximately equal numbers of patients in each ESRD 
stage). 
 
Ethical approval 
Ethics approval was obtained from the Coventry and Warwickshire Research Ethics Committee in October 
2015 [Ref 15/WM/0288]. The study was also approved by the Research Governance office of each of the 
participating hospital Trusts.  
 
Patient and public involvement 
The study design and research questions were developed with input from a study advisory group that 
included patient representatives, and the patient and public involvement (PPI) group attached to the chronic 
diseases theme of the CLAHRC West Midlands. These groups were also involved in selecting appropriate 
outcome measures that optimised data quality whilst minimising participant burden. Patients were not 
involved in recruitment to the study or its conduct. Study participants will be sent a plain English summary of 
final study results if they indicated during the informed consent process that they would like to receive this.   
 
RESULTS 
A total of 3730 surveys were sent across the four study sites. One hundred patients died between the initial 
and reminder mailings (2.7%) and 2442 recipients (65.5%) did not respond. Of the 1188 responses received 
(31.8%), 148 were removed due to non-completion of the emotion thermometers (4.0%), giving a total of 
1040 valid responses (27.9%) (Figure 1). Rates of valid responses ranged from 23.0% in site 1 to 30.4% in 
site 4.  Younger patients (<65 years old) were significantly less likely to respond than those aged 65 and 
over, as were those from BME groups compared to those in the white ethnic group. Patients yet to begin 
RRT and those on dialysis for less than 2 years were significantly less likely to respond than patients with a 
transplant or who had been undergoing dialysis for 2 or more years. There was no significant difference 
between responders and non-responders on the basis of sex (Table 1).  
 
Characteristics of respondents 
The majority of respondents were male (n=633; 60.9%) and in the white ethnic group (n=902; 86.7%) (Table 
2). Patients aged between 51 and 69 years old constituted the largest age group (n=441; 42.9%), with those 
aged under 50 comprising 16.9% of the total (n=174). Nearly two fifths of respondents had received a 
transplant (n=404; 38.8%) and 28.8% had been on dialysis for 2 or more years (n=300). Of the 454 patients 
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undergoing regular dialysis, the most common modality was hospital/in-centre haemodialysis (n=343; 
75.6%).  
 
Prevalence of distress 
A total of 561 respondents (53.9%) were categorised as having none to low distress, and a further 133 
patients (12.3%) met the criteria for severe distress (i.e. scoring greater than 7 on one or more of the 
emotion thermometers). A total of 346 respondents (33.3%) met the criteria for mild to moderate distress 
(hereafter termed ‘distress’). Distress prevalence by hospital site was lowest in site 4 (30.9%) and highest in 
site 1 (38.5%), although the difference between study sites was not statistically significant (X2 = 3.24; 
p=0.356). Distress was identified in 208 patients (60.1%) on the basis of their DT score alone, with the 
remaining 138 (39.9%) identified from their scores on the anxiety, depression or anger thermometers. 
Distress prevalence was highest in patients who had been on dialysis for 2 or more years (n=109/300; 
36.3%) and lowest in transplant patients (n=118/404; 29.2%). For dialysis modality, distress was most 
prevalent for home haemodialysis patients (n=13/31; 41.9%) and lowest in the peritoneal dialysis group 
(n=22/80; 27.5%), although numbers were small.  There was no significant difference in rates of distress on 
the basis of ESRD stage or dialysis type when groups were compared. In contrast, all sociodemographic 
characteristics showed significant differences in distress prevalence between groups. Patients in the 
youngest age group were significantly more likely to report distress than those in the older age groups 
(n=78/174; 44.8%; X2 = 14.33; p=0.0008). The prevalence of distress was significantly higher for females 
than males (38.1% vs. 30.2%; X2 = 6.63; p=0.01) and for BME patients compared to white patients (45.7% 
vs. 31.4%; X2 = 10.36; p=0.0013).  
 
Perceived need for help 
Scores on the ‘need’ thermometer were assessed as an outcome measure indicating patients’ perceived 
need for help. Scores of four and above were considered to indicate unmet support needs19 (Table 3). 
Patients at study sites 1 and 3 had significantly higher perceived support needs than those in sites 2 and 4 
(29.4% and 22.9% vs. 21.5% and 20.1%; X2 = 9.49; p=0.02). There were also significant differences by sub-
group according to ESRD stage: 66.0% of patients on dialysis for less than two years (n=35) required 
support, as did 55.7% of patients on dialysis for two or more years (n=59). Perceived support needs in the 
pre-RRT and transplant groups were significantly lower, at 34.9% and 29.9% respectively (X2 = 27.71; 
p<0.0001). Support needs were also significantly higher in BME compared to white patients, at 57.6% vs. 
37.9% (X2 = 7.06; p=0.008).  
 
Distress thermometer problem list 
All but six patients reported experiencing at least one problem on the DT problem list in the preceding week 
(98.0%) (Table 4). The most frequently reported problems were all in the emotional and physical domains, 
with 91.9% of patients reporting at least one emotional problem in the previous week, and 95.1% reporting at 
least one physical problem. ‘Worry’ was the commonest problem across all domains (n=247; 74.3%). 
‘Fatigue’ (71.7%), ‘dry/itchy skin’ (65.0%) and ‘sleep’ (61.3%) were the most common physical problems. 
‘Spiritual problems’ (6.6%) and ‘problems with childcare’ (family domain: 3.8%) were reported least 
frequently. The median number of total problems reported was 12/36 (IQR: 7 to 16) (Table 5).  
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Sub-group analysis shows that transplant patients reported significantly fewer physical problems and total 
problems than pre-RRT or dialysis patients (median physical problems 6/21, IQR 3 to 10, p=0.019; median 
total problems 10/36, IQR 5 to 16, p=0.023). Patients aged 70 and older reported significantly fewer 
problems on the practical, family and emotional domains than younger patients. They also reported 
significantly fewer total problems. Females reported significantly more physical problems than males (median 
8/21, IQR 5 to 12 vs. 7/21, IQR 5 to 11; p=0.043). 
 
DISCUSSION 
Detecting distress is important for the optimal care of patients with ESRD, and evidence suggests that 
reducing emotional and psychological difficulties may enhance wellbeing and improve patients’ ability to 
engage with complex and demanding treatments. Our study has shown that as many as one in three 
patients with ESRD may have mild to moderate distress, and rates of reporting emotional and physical 
problems were high. This was evident across the ESRD pathway, with around 35% of pre-RRT and dialysis 
patients and 29% of transplant patients meeting the criteria for mild to moderate distress. The finding that the 
prevalence of distress was almost as high in transplant patients as those undergoing dialysis suggests that 
although they may experience fewer physical problems, the need for ongoing psychological adjustment does 
not end at the point of transplantation.10 Mild to moderate distress was most prevalent in the group of 
patients who had been on dialysis for 2 or more years (36.3%), which may reflect a lack of adjustment and 
coping in this group with the ongoing challenges of undergoing regular dialysis treatment over an extended 
period, potentially declining health, and the limitations that dialysis treatment places on family, relationships 
and lifestyle. There was also variation by dialysis type, with patients receiving hospital/in-centre 
haemodialysis reporting distress rates of 37.6%, compared to 27.5% for patients undergoing peritoneal 
dialysis. Numbers were too small to detect statistically significant differences, but this distinction has been 
found elsewhere,23 and would benefit from further study.  
 
Distress prevalence was strongly associated with sociodemographic characteristics and was significantly 
higher in younger vs. older patients, in BME vs. white patients, and in females compared to males. These 
trends have also been found in studies of anxiety and depression in renal patients.24,25 There are numerous 
psychological theories of health and illness which may have a role in explaining patients’ variable responses 
to ESRD diagnosis and treatment.26-28 These theories emphasise that experience of distress is likely to be 
determined by an individual’s personal degree of resilience and individual coping resources rather than being 
associated with specific clinical characteristics. 
 
Comparable national figures for the pre-RRT group are not available, but if the prevalence of mild to 
moderate distress found in this study was standardised to the current population in England with a 
functioning transplant or undergoing dialysis, it would equate to 18,970 patients with ESRD experiencing 
difficulties, of whom 7,835 may want help.1 It has been argued that the primary goal of supportive services 
should be to distinguish between transient and ongoing difficulties and focus on optimising patients’ ability to 
cope with their condition.29 In this context, it is likely that the most feasible supportive interventions are those 
that can be incorporated into routine clinical practice and standard protocols for ESRD care. The ET could be 
used regularly by clinicians during patient consultations or by renal nurses to screen for distress. Screening 
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in itself will not necessarily lead to better patient outcomes, but it may help to identify patients whose distress 
would otherwise remain undetected, and in doing so, could enable the targeted provision of support services. 
 
Experiencing distress may be considered a normal response to chronic disease diagnosis, and not all 
patients with mild to moderate distress will want to receive support. The likelihood that patients with ESRD 
will experience symptoms of distress was predominantly associated with age, sex and ethnicity. 
Consequently, screening for distress would seem particularly important for younger patients, who may 
experience significantly greater disruption to their family and working life than older patients, females, and for 
patients in BME groups, who reported uniformly high rates of mild to moderate distress and high support 
needs. It may also be useful to target screening for distress towards those who undergo regular hospital or 
in-centre haemodialysis. Providing appropriate information to patients early on in the ESRD pathway (pre-
RRT) about the distress they may experience could also help to manage patients’ expectations and allow 
timely identification of emotional and psychological difficulties. There was also evidence of a centre effect in 
the proportion of patients reporting a perceived need for support at participating study sites. Patients in sites 
1 and 3, where there is no access to a renal psychologist reported significantly higher rates of support need 
than those in sites 2 and 4 where renal psychologist support is available. This suggests that the availability of 
in-house psychological support services may play an important role in helping patients with ESRD to 
manage distress.  
 
Limitations 
The survey response rate was low, and younger patients, those from BME groups and patients who had 
been more recently diagnosed were under-represented in responses. The study was marginally 
underpowered, with 1040 valid responses received, rather than the 1090 required by our a priori sample size 
estimation. We are also unable to say whether distress is more or less common in survey respondents 
compared to non-respondents, nor could we perform detailed sub-group analyses for patients within each 
ESRD pathway stage. This meant that participants in each ESRD pathway stage were treated as a 
homogeneous cohort when in reality there may have been differences between them that may have 
impacted on their experience of distress such as issues with medication or ESRD-related complications like 
fistula failure, infection or transplant failure. However, in-depth qualitative research was undertaken with 
renal patients to explore the detailed determinants and consequences of their distress in a linked component 
of this study (findings to be reported elsewhere).   
 
Nevertheless, our findings with regard to the patient groups most likely to experience distress were similar to 
existing evidence on anxiety and depression in renal disease. Because younger, BME patients were under-
represented in our sample, the finding that patients in these groups reported significantly higher rates of mild 
to moderate distress than older, white patients, suggests that we may have under-estimated rather than 
over-estimated overall distress prevalence. The inclusion of multiple study sites is likely to have minimised 
any bias that may arise from variations in the organisation and delivery of renal services. Patients referred to 
psychiatric services (as noted in their hospital record) were excluded, but we cannot know whether our 
sample included patients who had independently sought counselling or support via their general practitioner. 
The study was also cross-sectional rather than longitudinal, and consequently allows limited understanding 
of the relationship between time since ESRD diagnosis and ability to cope with the resulting stressors. Some 
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studies with renal patients have found no correlation between depressive symptoms and time since 
treatment initiation,9 whereas others have found a tendency for depression status to worsen.30 Future work 
using a cohort study design would aid understanding of the ways that individuals adapt to ESRD diagnosis 
and its ongoing management over time. 
 
CONCLUSION 
This study is, to our knowledge, the first to explore the prevalence of mild to moderate distress in a large 
cohort of patients with ESRD. Our findings show that mild to moderate distress is common – even after 
transplantation – and there may be substantial unmet patient support needs. Further research into possible 
variations in distress prevalence over time and at different transitional points across the ESRD pathway is 
needed, as is work to determine how best to support patients requiring help.   
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FIGURE LEGEND 
 
Figure 1: Surveys mailed and returned 
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TABLES 
 
Table 1: Comparison of the characteristics of survey responders and non-responders 
 
Characteristic Respondents (%) Non-respondents (%) Total Comparison of proportions  
     
Stage on ESRD pathway     
Pre-RRT 183 (24.6) 560 (75.4) 743  
Dialysis <2 years 162 (25.2) 481 (74.8) 643 X2 = 9.96; p=0.02 
Dialysis 2+ years 293 (30.0) 684 (70.0) 977  
Transplant 402 (29.4) 965 (70.6) 1367  
     
Age group†     
Less than 65 503 (24.7) 1537 (75.3) 2040 X2 = 19.86; p<0.0001 
65 and above 524 (31.3) 1151 (68.7) 1675  
     
Sex     
Male 635 (28.0) 1636 (72.0) 2271 X2 = 0.01; p=0.92 
Female 405 (27.8) 1054 (72.2) 1459  
     
Ethnicity‡     
White 902 (34.4) 1720 (65.6) 2622 X2 = 76.16; p<0.0001 
Black and minority ethnic 138 (17.9) 635 (82.1) 773  
† Age unknown for 15 patients; ‡ Ethnicity unknown for 335 patients; bold text indicates statistical significance 
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Table 2: Respondent characteristics and proportion by sub-group with mild to moderate distress 
Characteristic Respondents (%) 
Mild to moderate 
distress (%) 
Comparison of proportions 
(mild to moderate distress 
patients)† 
All respondents 1040 (100.0) 346 (33.3)  
    
Study site    
Site 1 187 (18.0) 72 (38.5)  
Site 2 177 (17.0) 58 (32.8) X2 = 3.24; p=0.356 
Site 3 323 (31.1) 107 (33.1)  
Site 4 353 (33.9) 109 (30.9)  
    
Stage on ESRD pathway    
Pre-RRT 182 (17.5) 64 (35.2)  
Dialysis <2 years 154 (14.8) 55 (35.7) X2 = 4.85; p=0.183 
Dialysis 2+ years 300 (28.8) 109 (36.3)  
Transplant 404 (38.8) 118 (29.2)  
    
Dialysis type (n=454)    
Hospital/in-centre haemodialysis 343 (75.6) 129 (37.6)  
Home haemodialysis 31 (6.8) 13 (41.9) X2 = 3.36; p=0.186 
Peritoneal dialysis 80 (17.6) 22 (27.5)  
    
Age group‡    
Less than 50 174 (16.9) 78 (44.8)  
50 to 69 441 (42.9) 145 (32.9) X2 = 14.33; p=0.0008 
70 and above 414 (40.2) 119 (28.7)  
    
Sex    
Male 633 (60.9) 191 (30.2) X2 = 6.63; p=0.01 
Female 407 (39.1) 155 (38.1)  
    
Ethnicity    
White 902 (86.7) 283 (31.4) X2 = 10.36; p=0.0013 
Black and minority ethnic 138 (13.3) 63 (45.7)  
†Bold text denotes a statistically significant difference between groups; ‡Age unknown for four respondents  
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Table 3: Perceived need for help with distress by sub-group with mild to moderate distress (n=346) 
Characteristic Median ‘need’ score (IQR) 
Patients scoring 4   
or more on need 
thermometer (%) 
Comparison of proportions 
(mild to moderate distress 
patients)† 
All respondents 3 (1 to 5) 141 (40.8)  
    
Study site    
Site 1 1 (0 to 4) 55 (29.4)  
Site 2 1 (0 to 3) 38 (21.5) X2 = 9.49; p=0.02 
Site 3 1 (0 to 3) 74 (22.9)  
Site 4 0 (0 to 3) 71 (20.1)  
    
Stage on ESRD pathway    
Pre-RRT 2 (0 to 4) 22 (34.9)  
Dialysis <2 years 3 (2 to 6) 35 (66.0) X2 = 27.71; p<0.0001 
Dialysis 2+ years 4 (2 to 6) 59 (55.7)  
Transplant 2 (0 to 4) 35 (29.9)  
    
Dialysis type (n=454)    
Hospital/in-centre haemodialysis 4 (2 to 6) 70 (56.0)  
Home haemodialysis 4 (2 to 8) 7 (53.8) X2 = 5.44; p=0.07 
Peritoneal dialysis 3 (0 to 5) 6 (28.6)  
    
Age group    
Less than 50 3 (2 to 5) 35 (44.9)  
50 to 69 3 (1 to 5) 55 (39.0) X2 = 0.85; p=0.654 
70 and above 3 (1 to 5) 48 (41.4)  
    
Sex    
Male 3 (1 to 5) 73 (39.2) X2 = 0.54; p=0.462 
Female 3 (1 to 5) 67 (43.8)  
    
Ethnicity    
White 3 (1 to 5) 106 (37.9) X2 = 7.06; p=0.008 
Black and minority ethnic 5 (2 to 7) 34 (57.6)  
†Bold text indicates a statistically significant difference between groups 
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Table 4: Number and proportion of patients reporting problems on the DT problem list 
Problems by domain Number of patients (%)† Patients reporting at least 1 problem for the domain (%) 
Any problems (n=36) - 339 (98.0) 
   
Practical domain (n=5)   
  Transport 84 (24.3)  
  Insurance/financial 76 (22.0)  
  Work 53 (15.3) 167 (48.3) 
  Housing 30 (8.7)  
  Childcare 13 (3.8)  
   
Family domain (n=3)   
  Dealing with friend/relative 66 (19.1)  
  Dealing with partner 60 (17.3) 118 (34.1) 
  Dealing with children 27 (7.8)  
   
Emotional domain (n=6)   
  Worry 257 (74.3)  
  Loss of interest in usual activities 186 (53.8)  
  Sadness 166 (48.0) 318 (91.9) 
  Depression 159 (46.0)  
  Nervousness 150 (43.4)  
  Fears 148 (42.8)  
   
Spiritual domain (n=1)   
  Spiritual/religious concerns 23 (6.6) - 
   
Physical domain (n=21)   
  Fatigue 248 (71.7)  
  Skin dry/itchy 225 (65.0)  
  Sleep 212 (61.3)  
  Memory/concentration 183 (52.9)  
  Pain 178 (51.4)  
  Getting around 171 (49.4)  
  Tingling in hands/feet 144 (41.6)  
  Breathing 133 (38.4)  
  Feeling swollen 127 (36.7)  
  Bathing/dressing 119 (34.4) 329 (95.1) 
  Appearance 116 (33.5)  
  Eating 111 (32.1)  
  Nose dry/congested 108 (31.2)  
  Constipation 106 (30.6)  
  Nausea 100 (28.9)  
  Changes in urination 94 (27.2)  
  Indigestion 92 (26.6)  
  Sexual 88 (25.4)  
  Diarrhoea 79 (22.8)  
  Mouth sores 42 (12.1)  
  Fevers 31 (9.0)  
†Problems within each domain ranked from most to least frequently cited by respondents 
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Table 5: Median number of problems reported in each DT problem list domain, by patient group 
Characteristic Practical†,‡ Family Emotional Physical Total 
Stage on ESRD pathway Median (IQR)§ Median (IQR) Median (IQR) Median (IQR) Median (IQR) 
Pre-RRT 1 (0 to 1) 0 (0 to 1) 3 (1 to 4) 8 (4 to 12) 12 (7 to 17) 
Dialysis <2 years 1 (0 to 2) 0 (0 to 1) 3 (2 to 5) 8 (6 to 12) 13 (9 to 17) 
Dialysis 2+ years 1 (0 to 1) 0 (0 to 1) 3 (2 to 5) 9 (6 to 11) 13 (9 to 16) 
Transplant 0 (0 to 1) 0 (0 to 1) 3 (1 to 4) 6 (3 to 10) 10 (5 to 16) 
    p=0.019 p=0.023 
Dialysis type (n=164)      
Hospital/in-centre 
haemodialysis 1 (0 to 1) 0 (0 to 1) 3 (2 to 5) 8 (5 to 11) 13 (8 to 16) 
Home haemodialysis 1 (0 to 2) 0 (0 to 1) 4 (2 to 5) 10 (8 to 13) 16 (11 to 19) 
Peritoneal dialysis 0 (0 to 1) 0 (0 to 1) 3 (2 to 4) 8 (6 to 11) 12 (9 to 16) 
      
Age group4      
Less than 50 1 (0 to 2) 0 (0 to 1) 3 (2 to 5) 7 (4 to 11) 13 (8 to 17) 
50 to 69 1 (0 to 2) 0 (0 to 1) 3 (2 to 5) 8 (5 to 11) 12 (8 to 18) 
70 and above 0 (0 to 1) 0 (0 to 0) 3 (1 to 4) 7 (4 to 10) 11 (7 to 15) 
 p<0.0001 p=0.001 p=0.038  p=0.033 
Sex      
Male 1 (0 to 1) 0 (0 to 1) 3 (2 to 4) 7 (4 to 10) 12 (7 to 16) 
Female 0 (0 to 1) 0 (0 to 1) 3 (2 to 5) 8 (5 to 12) 12 (8 to 17) 
    p=0.043  
Ethnicity      
White 0 (0 to 1) 0 (0 to 1) 3 (2 to 4) 8 (5 to 11) 12 (7 to 16) 
Black and minority ethnic 0 (0 to 2) 0 (0 to 1) 4 (1 to 5) 7 (4 to 10) 11 (7 to 17) 
      
All respondents (n=346) 0 (0 to 1) 0 (0 to 1) 3 (2 to 5) 8 (5 to 11) 12 (7 to 16) 
†Bold text denotes a statistically significant difference between groups (Mann Whitney test for characteristics 
with two sub-groups; Kruskall Wallis test for characteristics with three or more sub-groups); ‡Spiritual domain 
excluded from analysis; §IQR = inter-quartile range 
 
